![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Serum levels of testosterone, luteinizing hormone and follicle-stimulating hormone were measured in 73 patients with germ cell testicular cancer in stages I and II. Blood samples were taken after unilateral orchidectomy but immediately before irradiation and chemotherapy, and again 1 to 3 years after cessation of therapy. No difference was found between pre- and post-treatment testosterone values. Patients who received radiotherapy only, had similar pre- and post-treatment luteinizing hormone values, whereas the patients who received chemotherapy in addition to irradiation still had elevated luteinizing hormone values 1 to 3 years after cessation of therapy. These values fell towards the pretreatment levels during the follow-up period. Levels of follicle-stimulating hormone were already higher than normal before treatment and increased further during treatment.